CONTEXT: Perineuriomas are benign peripheral nerve sheath neoplasms composed of perineurial cells with characteristic immunohistochemical and ultrastructural features. They have been traditionally classified into two main types according to their location--intraneural and extraneural--and overlap histologically with many other tumors, which may be diagnostically challenging to general surgical pathologists. OBJECTIVE: To review the clinical, morphologic, immunohistochemical, ultrastructural, cytogenetic, and molecular genetic aspects of perineurioma, as well as to discuss its clinicopathologic variants and differential diagnosis. DATA SOURCES: English-language literature published between 1966 and 2005 was reviewed. CONCLUSIONS: The correct identification of perineuriomas is important to avoid unnecessary overtreatment. The histologic diagnosis should be confirmed through immunohistochemical studies (including epithelial membrane antigen, S100 protein, and more recently described antibodies such as claudin-1 and GLUT1) or electron microscopy. Cytogenetic and molecular genetic studies are still of limited value for the diagnosis of perineuriomas but may play a fundamental role in excluding important differential diagnoses and also in helping elucidate the biology of these poorly known neoplasms.
CONTEXT: Perineuriomas are benign peripheral nerve sheath neoplasms composed of perineurial cells with characteristic immunohistochemical and ultrastructural features. They have been traditionally classified into two main types according to their location--intraneural and extraneural--and overlap histologically with many other tumors, which may be diagnostically challenging to general surgical pathologists. OBJECTIVE: To review the clinical, morphologic, immunohistochemical, ultrastructural, cytogenetic, and molecular genetic aspects of perineurioma, as well as to discuss its clinicopathologic variants and differential diagnosis. DATA SOURCES: English-language literature published between 1966 and 2005 was reviewed. CONCLUSIONS: The correct identification of perineuriomas is important to avoid unnecessary overtreatment. The histologic diagnosis should be confirmed through immunohistochemical studies (including epithelial membrane antigen, S100 protein, and more recently described antibodies such as claudin-1 and GLUT1) or electron microscopy. Cytogenetic and molecular genetic studies are still of limited value for the diagnosis of perineuriomas but may play a fundamental role in excluding important differential diagnoses and also in helping elucidate the biology of these poorly known neoplasms.
Authors: Hye Jeong Kim; Ik Yang; Ah Young Jung; Ji Young Woo; Hye Suk Hong; Su Kyung Jeh; Hong Kyun Kim; Jeong Won Kim Journal: Skeletal Radiol Date: 2010-10-31 Impact factor: 2.199
Authors: Michelle L Mauermann; Kimberly K Amrami; Nancy L Kuntz; Robert J Spinner; Peter J Dyck; E Peter Bosch; Janean Engelstad; Joel P Felmlee; P James B Dyck Journal: Brain Date: 2009-06-30 Impact factor: 13.501
Authors: David K Meyerholz; Georgina K Ofori-Amanfo; Mariah R Leidinger; J Adam Goeken; Rajesh Khanna; Jessica C Sieren; Benjamin W Darbro; Dawn E Quelle; Jill M Weimer Journal: J Histochem Cytochem Date: 2017-08-28 Impact factor: 2.479
Authors: Susan A Elmore; Mark F Cesta; Torrie A Crabbs; Kyathanahalli S Janardhan; Gregory A Krane; Debabrata Mahapatra; Erin M Quist; Matthias Rinke; George W Schaaf; Gregory S Travlos; Haoan Wang; Cynthia J Willson; Jeffrey C Wolf Journal: Toxicol Pathol Date: 2019-10-23 Impact factor: 1.902